Latest Articles

Subject

Article
Converging mediators from immune and trophic pathways to identify Parkinson disease dementia
Lih-Fen Lue, Christopher T. Schmitz, Noelle L. Snyder, et al.

January 27, 2016
Article
Cytokine profiles show heterogeneity of interferon-β response in multiple sclerosis patients
Harald Hegen, Indra Adrianto, Christopher J. Lessard, et al.

January 27, 2016
Article
Serum lipid antibodies are associated with cerebral tissue damage in multiple sclerosis
Rohit Bakshi, Ada Yeste, Bonny Patel, et al.

January 27, 2016
Clinical/Scientific Notes
Autopsy-proven demyelination associated with infliximab treatment
Michael J. Bradshaw, Bret C. Mobley, Jeffrey P. Zwerner, et al.

January 27, 2016
Article
Mycoplasma pneumoniae, a trigger for Weston Hurst syndrome
Rick Magun, Chris P. Verschoor, Dawn M.E. Bowdish, et al.

January 21, 2016
Article
Alemtuzumab long-term immunologic effectTreg suppressor function increases up to 24 months
Stefania De Mercanti, Simona Rolla, Angele Cucci, et al.

January 21, 2016
Article
Rituximab monitoring and redosing in pediatric neuromyelitis optica spectrum disorder
Margherita Nosadini, Gulay Alper, Catherine J. Riney, et al.

January 21, 2016
Article
Lipocalin-2 is increased in progressive multiple sclerosis and inhibits remyelination
Faiez Al Nimer, Christina Elliott, Joakim Bergman, et al.

January 07, 2016
Article
Humoral response to EBV is associated with cortical atrophy and lesion burden in patients with MS
Robert Zivadinov, Nicole Cerza, Jesper Hagemeier, et al.

January 07, 2016
Clinical/Scientific Notes
The severe side of the IgG4-related hypertrophic pachymeningitis disease spectrum
Ryan D. Schubert, Matthew Wood, Marc H. Levin, et al.

January 07, 2016

Pages